US drugmaker Eli Lilly enjoyed a good day on the obesity front on Wednesday, with the news that its GLP-1 receptor agonist tirzepatide - branded as Wegovy and Mounjaro - outscored its main rival from ...

AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while ...

Massachusetts, USA-based clinical stage biotech Rgenta Therapeutics, which is developing a new class of oral small molecules ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Shares of US precision medicines firm Relay Therapeutics closed down 6% at $4.39 yesterday after announced a licensing deal ...

Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has ...

Brexit by the ABPI, emphasizing the need for more resources and flexible licensing. The regulator faces challenges including ...

Chinese biotech Duality Biologics yesterday revealed that it has entered into an exclusive option agreement with UK pharma ...

Cartesian Therapeutics reports positive Phase IIb results for Descartes-08 in generalized myasthenia gravis, achieving ...

The battle between the two front runners in the vast weight loss released top-line results from the SURMOUNT-5 Phase IIIb ...

UK’s MHRA is called to restore its reputation post-Brexit by the ABPI, emphasizing the need for more resources and flexible ...

Refoxy Pharmaceuticals secures €9.1 million in seed-extension funding led by Boehringer Ingelheim Venture Fund to advance its ...